Urine test could personalize bladder cancer treatment, potentially shortening therapy
NCT ID NCT07475403
Summary
This study is testing whether a urine test that detects cancer DNA can help doctors decide how long to continue immunotherapy in patients with a high-risk form of bladder cancer that cannot be fully removed by surgery. Participants will receive immunotherapy, and if their cancer disappears, they will get a short additional course before stopping treatment, guided by the urine test results. The goal is to see if this shorter, personalized treatment plan can still effectively control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Hospital of Tianjin Medical University
RECRUITINGTianjin, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.